| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $400K | +77.8% |
| R&D Expense | $8.3M | +60.3% |
| SG&A Expense | $10.7M | -8.4% |
| Operating Income | -$18.6M | -11.8% |
| Income Tax | $0 | — |
| Net Income | -$18.4M | +26.2% |
| EPS (Basic) | -$1.75 | +73.1% |
| EPS (Diluted) | -$1.75 | +73.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -39.6% |
| Accounts Receivable | $0 | — |
| Current Assets | $9.7M | -38.0% |
| Total Assets | $23.2M | -19.3% |
| Current Liabilities | $6.1M | +59.0% |
| Total Liabilities | $8.3M | +12.1% |
| Stockholders' Equity | $14.9M | -30.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | +17.5% |
| Capital Expenditures | $16K | -92.4% |
| Investing Cash Flow | $742K | -18.1% |
| Financing Cash Flow | $8.9M | -63.5% |
| Free Cash Flow | -$15.3M | +18.4% |